FDA Approved: LYUMJEV — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approves LYUMJEV as an original Biologics License Application from Eli Lilly for glycemic control in people with diabetes mellitus, marking the initial appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lyumjev (insulin lispro)

Snippet

ORIG AP for LYUMJEV (INSULIN LISPRO-AABC)